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Background: The exact etiology of recurrent tonsillopharyngitis in children is not clear. Recurrent tonsillitis in
children has multifactorial etiology like most of the diseases in childhood. In this study, our aim was to determine
the potential role of vitamin D in recurrent tonsillitis by measuring serum 25-OH vitamin D levels and determining
the vitamin D receptor polymorphism among children with recurrent tonsillitis.
Methods: Eighty-four children with recurrent tonsillitis and seventy-one healthy children aging between 2 and
10 years were enrolled in this study. Serum 25-OH vitamin D level was measured with ELISA and vitamin D receptor
gene polymorphism (Apa1, Taq 1, Fok1) was determined by PCR. Serum 25-OH vitamin D level below 50 nmol/L
was accepted as deficiency. The vitamin D receptor gene polymorphism in each group was compared.
Results: The mean age was 5.6 ± 2.4 and 6.1 ± 2.7 years in study and control group, respectively. The average
serum 25-OH vitamin D level was 142.7 ± 68.1 nmol/L in study group and 192.3 ± 56.1 nmol/L in control group.
There was significant difference between the groups (p < 0.01). In study group, 4.7% (n = 4) of children had serum
25 OH vitamin D levels below 50 nmol/L. None of the children in control group had serum 25-OH vitamin D level
below 50 nmol/L. There was no significant differences in vitamin D receptor gene polymorphisms between groups.
Conclusion: Serum 25-OH vitamin D levels in recurrent tonsillitis group were lower than those in healthy children.
But, there was no difference in the incidence of vitamin D receptor gene polymorphism between the two groups.
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Tonsillopharyngitis is one of the leading causes of
hospital visits during childhood and defined as the
acute infection of tonsil and pharynx, characterized by
erythema, exudation, ulceration or membrane [1]. It is
a major health issue due to its frequent nature, caus-
ing labour loss and leading to unreasonable antibiotic
use [2]. Besides viruses as the most frequent cause in
etiology, the Group A Beta-haemolytic streptococci is the
most commonly isolated bacteria [3]. As described by
Paradise, at least 7 or more episodes of tonsillopharyngitis
in a year or at least 5 episodes of acute tonsillitis in a year
for two consequetive years or at least 3 or more episodes
of acute tonsillitis in a year for three consequetive years is* Correspondence: eminu@istanbul.edu.tr
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reproduction in any medium, provided the oraccepted as recurrent tonsillopharyngitis [4]. Although
many factors are established for the cause of frequent ton-
sillopharyngitis, the exact cause has not been identified
yet. The environmental conditions, the child’s immune
system, mucosal characteristics effecting the bacterial bio-
film formation on tonsillar tissue and the respond to the
infections are of importance [5]. Antibiotics are not effect-
ive if bacterial biofilm occurred. Vitamin D has a prevent-
ive role for inhibition of bacterial biofilm. Even if the
frequency of the disease during the winter is explained by
environmental factors such as being indoor during winter,
being deprived of sun light is also a point attracting atten-
tion. The most important factor provided by the sun is
the production of vitamin D. Previous research sug-
gests that vitamin D has an important role in immune
system [6]. Vitamin D has an important role in main-
taining of innate immunity. Assignation of vitamin D
receptors (VDR) in many tissues has presented newtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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D has numerous effects on different cells types of the
immune system such as dendritic cells, B lymphocytes,
T lymphocytes, NK cells [7-9]. Some polymorphism
characteristics have been described regarding VDR
gene affected by vitamin D. The frequently studied
ones are Fok I, Bsm, Apa and Taq polymorphisms. Re-
lation has been established between polymorphisms
and some diseases [10,11].
In this study, our aim is to determine the role of the poly-
morphism characteristics of vitamin D and VDR receptors
in children diagnosed with recurrent tonsillopharyngitis.
Material and methods
Study design
This clinical retrospective study was carried out
among 242 children between 2 and 10 years of age
performed in Istanbul University, Istanbul Medical
Faculty, Department of Pediatrics, Outpatient Clinic of
General Pediatrics between April 2008 and April 2009.
During this period, the total number of access to the
outpatient clinic was 58933. Four-point seven percent
(2780) of these were due to acute tonsillopharyngitis.
A hundred and fifteen of these met the eligilbility cri-
teria and included to the study group (115/2780;
4.1%). A hundred and twenty-seven healthy children
followed for different problems by outpatient clinic of
the same institution included to the control group.
This study was conducted mostly in autumn and win-
ter seasons because of the increased frequency of
tonsillopharyngitis during those seasons and seasonal
variability of the vitamin D levels. Blood samples were
collected from both groups and were studied in the
same season. There were 115 cases who met the eligi-
bility criteria of the study. The kit used for this study
was designed to run 96 samples for both 25(OH) vita-
min D and 1,25-(OH) vitamin D. Twelve out of 96
were used to measure 25(OH) vitamin D and 1,25-
(OH) vitamin D levels during the preparation phase of
the study. Thus, 25(OH) vitamin D and 1,25(OH)2
vitamin D levels were measured for 84 out of 115 sub-
jects (Figure 1).
The eligibility criteria for participants
Inclusion criteria for the study group are as follows;
a) Having tonsillopharyngitis more than 7 times a year,
b) Having symptoms of tonsillopharyngitis developed
within last 7 days,
c) No conditions requiring to be hospitalized,
d) Given parental consent,
e) No known chronic diseases,
f ) Not having any supplementation of vitamin D
during the last 3 month.Tonsillopharyngitis
Tonsillopharyngitis is diagnosed depending on the
physical examination performed by a physician and
subjects included to the the study regardless of the
etiology, without performing any further microbiologic
testing for the distinction of the viral or bacterial causes.
The subjects that were diagnosed as tonsillopharyngitis
more than 7 times in a year are considered as frequent
tonsillopharyngitis. The frequency of tonsillopharyngitis
in a year is investigated by reviewing the hospital
records and by referring the feedback of parents if
the patient is diagnosed with tonsillopharyngitis in a
different institution or a prescription for tonsillophar-
yngitis was given by another physician previously.Measurement of serum vitamin D level and determination
of vitamin D receptor (VDR) gene polymorphism
In this study serum 25(OH) and 1,25-(OH) vitamin D
levels were measured by sandwich Enzyme Linked
Immunosorbent Assay (ELISA) method. DNA of the sub-
jects was isolated from the blood samples obtained and
VDR’s Apa, Taq , Fok I polymorphisms were determined
through primer series [12,13].Interpretation of serum vitamin D levels
Serum 25(OH) vitamin D level was interpreted as insuf-
ficient, sufficient, excess and intoxication if the blood
level was between 50–80 nmol/L, 80–250 nmol/L, 250–
325 nmol/L and above 325 nmol/L. Serum 25(OH)
vitamin D level below 50 nmol/L was accepted as apper-
ent deficiency (14) while the normal range of Serum 1,25-
(OH)2 vitamin D was considered as 16–65 pg/ml [14].Factors affecting serum vitamin D level
Daily exposure to sunlight, gender, age, weight,, and the
amount of time spent with outdoor activities and at sea-
side were investigated in both groups.Ethical committee approval and support
Istanbul University, Istanbul Shool of Medicine ethical
committee approval was taken in January 2008 with the
file numbered 2008/35 before the study was performed.
This study was supported by Istanbul University Scientific
Research Projects (Project No: 2006).Statistical analysis
In the evaluation of the qualitative and quantitative
parameters, Student’s t-test, Chi-Square, Fisher’s exact
chi-square, Pearson correlation analysis and logistic
regression tests were utilized. Statistical analyses were
made by SPSS 10.0 software program. The threshold for
significance was p < 0.05.
Figure 1 Flow chart of the study.
Table 1 Main characteristics of the cases
GROUPS P value
Study Group Control Group
(n:115) (n:127)
Gender Girl; n (%) 45 (39.1) 57 (44.9) 0.36
Age (years) 5.6 ± 2.4 6.1 ± 2.7 0.13
Weight (kg) 21.3 ± 8.0 21.8 ± 8.7 0.72
Height (cm) 113.8 ± 16.2 112.8 ± 19.3 0.74
Annual tonsillopharyngitis
frequency
15.3 ± 4.7 2.5 ± 0.9 <0.01
Study group consisted of the cases having frequent tonsillopharyngitis and
control group consisted of healthy cases.
Yildiz et al. Italian Journal of Pediatrics 2012, 38:25 Page 3 of 6
http://www.ijponline.net/content/38/1/25Results
The characteristics of the groups were as follows: 39.1%
of study group (n: 45) and 44.9% of control group (n: 57)
were girls (p = 0.36). The average age of study group was
5.6 ± 2.4 years and control group was 6.1 ± 2.7 years
(p = 0.13). The average weight of study group was
21.3 ± 8.0 kg and of control group was 21.8 ± 8.7 kg
(p = 0.72). The average height of study group was
113.8 ± 16.2 cm and of control group was 112.8 ± 19.3 cm
(p = 0.74; Table 1). The average annual frequency of
tonsillopharyngitis of study group was 15.3 ± 4.7 times
and control group was 2.5 ± 0.9 times (p < 0.01).
In study group, 25(OH) vitamin D level was studied in
84 of 115 cases (84/115; 73%). The average serum 25
(OH) vitamin D level was 142.7 ± 68.1 nmol/L. The
lowest serum 25(OH) vitamin D level was measured as
18 nmol/L and the highest level was 331 nmol/L. Serum
25 (OH) vitamin D level of 4 cases (4/84; 4.7%) was
below 50 nmol/L, which was considered as the cut off
for vitamin D deficiency. The values of these 4 caseswere measured as 18, 24, 39, 49 nmol/L. In one case,
serum 25(OH) vitamin D level was found above
325 nmol/L considered as above the intoxication limit.
In control group, 25(OH) vitamin D level was studied in
71 of 127 cases (71/127; 55.9%). The average serum 25
(OH) vitamin D level was 192.3 ± 56.1 nmol/L. The
Table 2 Serum levels of 25-OH vitamin D levels were







Serum 25(OH) vitamin D level
(nmol/L)
142.7 ± 68.1 192.3 ± 56.1 <0.01
Serum 1,25-(OH)2 vitamin
D level (pg/mL)
35.8 ± 16.4 28.4 ± 14.1 <0.01
Number of patients with serum
25-OH vitamin D level
below <50 nmol/L
4 (4/84; 4,5%) 0 0.04
Serum 1,25 (OH)2 vitamin D was measured in 84 patients in study group and
79 patients in control group.
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level was 303.7 nmol/L. No cases were found at defi-
ciency or intoxication limit in control group. The average
serum 25(OH) vitamin D level of study group was signifi-
cantly lower than that of control group (p < 0.01) (Table 2
and Figure 2).
In study group, serum 1,25-(OH)2 vitamin D level was
also studied in 84 of 115 cases (73%). The average serum
1,25-(OH)2 vitamin D level was 35.8 ± 16.4 pg/ml. The
lowest level was measured as 12.2 pg/ml and the highest
level was 81.5 pg/ml. In 3 cases, 1,25-(OH)2 vitamin D level
was below normal limit (Values: 12.2, 13.5, 13.7 pg/ml). In
6 cases, 1,25-(OH)2 vitamin D level was above normal
limit (Values: 66.2, 78.8, 80.1, 80.4, 80.5, 81.5 pg/ml). In
control group, serum 1,25-(OH)2 vitamin D level was
studied in 79 of 127 cases (62.2%). The average serum
1,25-(OH)2 vitamin D level was 28.6 ± 14.1 pg/ml. The
lowest level was measured as 7.4 pg/ml and the highest
level was 66.2 pg/ml. In 10 cases from control group,
1,25-(OH)2 vitamin D level was below normal limitFigure 2 Serum 25-(OH) vitamin D levels. Serum 25-OH vitamin D levels
group.(Values: 7.4, 7.9, 8.1, 8.2, 10.4, 10.8, 10.9, 11.5, 13,
14.3 pg/ml). In one case, 1,25-(OH)2 vitamin D level
was above normal limit (66.2 pg/ml). The average
1,25-(OH)2 vitamin D level of study group was signifi-
cantly higher than that of control group (p < 0.01).
Regarding Taq, Apa and Fok I polymorphisms in VDR
receptor gene, no statistically significant difference was
found between study and control groups (p values: 0.99,
0.14, 0.55, respectively, Table 3).
In multivariate analysis, the most efficient parameters
on annual disease frequency were serum 25(OH) vitamin
D and 1,25(OH)2 vitamin D levels; the annual disease
frequency increases with “Ff” polymorphism, whereas
decreases with “ff” polymorphism.Discussion
The existence of VDRs in immune system cells and dif-
ferent modulatory effects upon the stimulation of these
receptors have brought forward the relation of vitamin
D and immune system [5,6]. The best parameter for the
evaluation of vitamin D level and vitamin D pool in the
body is serum 25 (OH) vitamin D levels, whose half life
of is about 20 days [13-15]. Since the half life of the bio-
logically active form, 1,25-(OH)2 vitamin D is as short as
3 to 6 hours and the circulating blood level is very low
compared to 25(OH) vitamin D, its use is not preferred
for the evaluation of serum vitamin D levels [16]. In our
research, we studied the level of 25(OH) vitamin D
which gives information on body vitamin D storage and
also the level of biologically active form, 1,25-(OH)2 vita-
min D together. Due to the ease of the technique, serum
25(OH) vitamin D and 1,25-(OH)2 vitamin D levels were
measured by ELISA method. Vitamin D is effective on
all other systems apart from its important role in bonewere measured in 84 cases in study group and in 71 cases in control
Table 3 Vitamin D receptor gene polymorphism
VDR Gene
Polymorphisms
Study Group Control Group P value
(n:100) (n; (%)) (n:104) (n; (%))
Taq TT 49 (49) 50 (48.5) 0.99
Tt 40 (40) 42 (40.8)
tt 11 (11) 11 (10.7)
Apa AA 39 (39) 43 (42.6) 0.14
Aa 53 (53) 58 (57.4)
aa 8 (8) 0 (0)
Fok I FF 46 (45.5) 54 (53.5) 0.55
Ff 52 (51.5) 41 (40.6)
ff 3 (3) 6 (5.9)
VDR gene polymorphism was analyzed in 100 cases for study group and in
104 cases for control group.
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our study has been carried out on children having fre-
quent tonsillopharyngitis that is not associated with
bone-mineral system; serum calcium, phosphorous, alka-
line phosphatase and parathormone levels were not
measured.
The human VDR is polymorphic [16]. Recently, a
relation was established between VDR gene poly-
morphisms and predisposition to some diseases [10].
Presence of the t allele of the TaqI VDR receptor poly-
morphism is associated with increased anti-infective
action against tuberculosis [17,18]. In contrast, pres-
ence of the f allele of the FokI VDR polymorphism is
associated with reduction in anti-infective action
against tuberculosis [17,19]. The significance of VDR
polymorphisms on vitamin D production and activity
is a developing field. We tried to establish a relation
between VDR gene polymorphism and frequent tonsil-
lopharyngitis in children. In our study, we observed
that annual disease frequency increases in the patients
with “Ff” polymorphism, whereas it decreases in those
ones with “ff” polymorphisms. Our findings were in
contrast with the literature demonstrating negative cor-
relation between VDR ff allele polymorphism and re-
current tonsillopharyngitis [20].
Although the average serum 25-(OH) vitamin D levels
were in the normal range in both groups, it was signifi-
cantly lower in the children with frequent tonsillophar-
yngitis (p < 0.01). In our study, we tried to determine
the serum 25-(OH) vitamin D level that effectively pre-
vents tonsillopharyngitis. However, because of the lim-
ited number of cases in our study, we were not able to
make this assessment. But some preliminary data
showed that serum 25-OH vitamin D levels are lower in
patients with recurrent tonsillopharyngitis [21]. Two
randomized controlled trails reported that, vitamin D
supplementation is effective for prevention of upper re-
spiratory tract infections [22,23]. To determine theminimal serum vitamin D level necessary to protect
against upper respiratory tract infections, more cohort
studies with a larger number of cases are needed. The
difference of serum 1,25-(OH)2 vitamin D levels between
the groups may be because of the short half-life of
serum 1,25-(OH)2 vitamin D and the difference in study
timing of the samples at the laboratory.
Aydin and colleagues [24] conducted a prospective
research. Aydin and colleagues checked the serum 25-
(OH) vitamin D levels in tonsillectomy patients with re-
current tonsillitis, whilst our group checked the serum
25- (OH) vitamin D and 1.25 (OH) 2 vitamin D levels
of children with frequent tonsillopharyngitis. Whilst
both studies into serum 25- (OH) vitamin D levels were
within the normal range, Aydin and colleagues found
no statistical differences with the control group. Our
study did show a statistical difference.
In our study, the children who had recurrent tonsillo-
pharyngitis during the one-year period were determined
and their serum vitamin D levels were studied. Since
vitamin D is affected by external factors and displays
seasonal differences in particular, studying serum vita-
min D levels by means of taking serum samples in both
summer and winter would have been ideal. Evaluating
the nutritional characteristics of the children would
make the study more reliable.
In conclusion, based on this study, low serum vitamin
D level can be a risk factor for recurrent tonsillophar-
yngitis. In children having recurrent tonsillopharyngitis,
serum 25(OH) vitamin levels were lower than those of
healthy children. But, there was no difference in vita-
min D receptor gene polymorphism. In the future, giv-
ing vitamin D support to the children with recurrent
tonsillopharyngitis, then measuring their serum vitamin
D levels and observing the decrease in annual disease
frequency after the supportive treatment would exactly
explain the relation between vitamin D and having
recurrent tonsillopharyngitis.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
IY, EU, AK and SA carried out the clinic studies. UZ, BT and CC participated in
measurements of the levels of vitamin D. ST carried out the statistical
analysis. All authors participated to drafted the manuscript. All authors read
and approved the final manuscript.
Author details
1Istanbul Medical Faculty, Department of Pediatrics, Istanbul University,
Istanbul, Turkey. 2Institute of Experimental Medical Researches, Department
of Molecular Medicine, Istanbul University, Istanbul, Turkey. 3Medical Faculty,
Department of Forensics Medicine, Zonguldak Karaelmas University,
Zonguldak, Turkey. 4Istanbul Medical Faculty, Department of ENT Clinic,
Istanbul University, Istanbul, Turkey. 5Istanbul Tıp Fakultesi, Cocuk Klinigi,
Capa, Istanbul 34390, Turkey.
Received: 26 September 2011 Accepted: 7 May 2012
Published: 8 June 2012
Yildiz et al. Italian Journal of Pediatrics 2012, 38:25 Page 6 of 6
http://www.ijponline.net/content/38/1/25References
1. Armstrong GL, Pinner RW: Outpatient visits for infectious diseases in the
United States, 1980 through 1996. Arch Intern Med 1999, 159:2531–2536.
2. Makela MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimaki M,
Blomqvist S, Hyypia T, Arstila P: Viruses and bacteria in the etiology of the
common cold. J Clin Microbiol 1998, 36:539–542.
3. Alan L, Bisno MD: Acute pharyngitis: etiology and diagnosis. Pediatrics
1996, 97:949–954.
4. Paradise JL, Bluestone CD, Colborn DK, Bernard BS, Rockette HE, Kurs-Lasky
M: Tonsillectomy and adenotonsillectomy for recurrent throat infection
in moderately affected children. Pediatrics 2002, 110:7–15.
5. Kania RE, Lamers GE, Vonk MJ, Huy PT, Hiemstra PS, Bloemberg GV, Grote JJ:
Demonstration of bacterial cells and glycocalyx in biofilms on human
tonsils. Arch Otolaryngol Head Neck Surg 2007, 133:115–121.
6. Bartley J: Vitamin D, innate immunity and upper respiratory tract
infection. J Laryngol Otol 2010, 124:465–469.
7. Deluca HF, Cantorna MT: Vitamin D: its role and uses in immunology.
FASEB J 2001, 15:2579–2585.
8. Van Etten E, Mathieu C: Immunregulation by1,25-dihydroxyvitamin D3:
basic concepts. J Steroid Biochem Mol Biol 2005, 97:93–101.
9. Zmuda JM, Cauley JA, Ferrell RE: Molecular epidemiology of vitamin D
receptor gene variants. Epidemiol Rev 2000, 22:203–217.
10. Valdivielso JM, Fernandez E: Vitamin D receptor polymorphisms and
diseases. Clin Chim Acta 2006, 371:1–12.
11. Bell NH, Morrison NA, Nguyen TV, Eisman J, Hollis BW: Apa I
polymorphisms of the vitamin D receptor predict bone density of the
lumbar spine and not racial difference in bone density in young men.
J lab Clin Med 2001, 137:133–140.
12. Vogel A, Strassburg CP, Manns MP: Genetic association of vitamin D
receptor polymorphisms with primary biliary chirrhosis and autoimmune
hepatitis. Hepatology 2002, 35:126–131.
13. Grant WB, Holick MF: Benefits and requirements of vitamin D for optimal
health: a review. Altern Med Rev 2005, 10:94–111.
14. Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D
concentrations, and safety. Am J Clin Nutr 1999, 69:842–856.
15. Adams JS, Hollis BW: Vitamin D: Synthesis, metabolism and clinical
measurement. In Disorders of bone and mineral metabolism. In Disorders
of bone and mineral metabolism. 2nd edition. Edited by Coe FL, Favus MJ.
Philadelphia: Lippincott Williams & Wilkins; 2002:157–174.
16. Uitterlinden A, Fang Y, Van Meurs J, Pols H, Van Leeuwen J: Genetics
and biology of vitamin D receptor polymorphisms. Gene 2004,
338:143–156.
17. Selvaraj P, Chandra G, Jawahar M, Rani M, Rajeshwari D, Narayanan P:
Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq
I, and Fok I polymorphisms on macrophage phagocytosis and
pymphoproliferative response to mycobacterium tuberculosis antigen in
pulmonary tuberculosis. J Clin Immunol 2004, 24:423–432.
18. Roth D, Soto G, Arenas F, Bautista C, Ortiz J, Rodriguez R, et al:
Association between vitamin D receptor gene polymorphisms and
response to treatment of pulmonary tuberculosis. J Infect Dis 2004,
190:920–927.
19. McGrath JJ, Saha S, Burne THJ, Eyles DW: A systematic review of the
association between common single nucleotide polymorphisms and
25-hydroxyvitamin D concentrations. J Steroid Biochemistry and Molecular
Biology 2010, 121:471–477.
20. Roth DE, Jones AB, Prosser C, Robinson JL, Vohra S: Vitamin D receptor
polymorphisms and the risk of acute lower respiratory tract infection in
early childhood. J Infect Dis 2008, 197:676–680.
21. Reid D, Morton R, Salkeld L, Bartley J: Vitamin D and tonsil
disease- Preliminary observation. Int J Ped Otorhinolaryngol 2011,
75:261–264.
22. Laaski I, Ruohola P, Mattilia V, Auvinen A, Vlikanin T, Pihlajamaki H: Vitamin
D supplementation for the prevention of acute respiratory tract
infections.A randomized double-blinded trial amongst young Finnish
men. J Infect Dis 2010, 202:809–814.23. Li-Ng M, Aloia JF, Polleck S, Cunha BA, Mikhail M, Yeh J, et al: A randomized
controlled trial of vitamin D3 supplementation for the prevention of
symptomatic upper respiratory tract infections. Epidemiol Infect 2002,
137:1396–1404.
24. Aydın S, Aslan I, Yıldız I, Ağaçhan B, Toptaş B, Toprak S, Değer K, Oktay MF,
Unüvar E: Vitamin D levels in children with recurrent tonsillitis. Int J
Pediatr Otorhinolaryngol 2011, 75:364–367.
doi:10.1186/1824-7288-38-25
Cite this article as: Yildiz et al.: The role of vitamin D in children with
recurrent Tonsillopharyngitis. Italian Journal of Pediatrics 2012 38:25.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
